The nm23 gene seems so far to be the most promising candidate for a gene with metastasis-suppressor function. It was originally identified in differential hybridisation experiments involving murine K-1735 melanoma cell line clones of varying metastatic potential (Steeg et al., 1988) . A tumour metastasis-suppressor function was implicated by the reduced expression of nm23 in highly metastatic sublines compared with non-metastatic sublines derived from the same K-1735 clone (Steeg et al., 1988; Rosengard et al., 1989; Leone et al., 1991) . Two closely related homologues of this gene, namely nm23-HJ and nm23-H2, have been found, both of which map to the chromosomal locus 17q21.3 (Backer et al., 1993) . They encode 18 kDa and 17 kDa proteins respectively, which have been demonstrated to shave nucleoside diphosphate kinase (NDPK) activity (Biggs et al., 1990; Lacombe et al., 1990; Gilles et al., 1991) . The nm23-H2 gene product was recently shown to be the c-myc transcription factor PuF (Postel et al., 1993) . The transfection of nm23 cDNA into low nm23-expressing and highly metastatic murine melanoma and human breast cancer cell lines reduced their metastatic potential, independent of growth rate, and further stratified their suppressor role in these tumour cohorts (Leone et al., , 1993a . Down-regulation of the nm23-HJ gene expression due to mutation and its allelic deletion at the 17q21.3 chromosomal locus, which might abrogate its suppressor role, has been implicated in metastasis formation of some human tumour types (Bevilacqua et al., 1989; Cohn et al., 1991; Hennessy et al., 1991; Hirayama et al., 1991; Leone et al., 1991; Nakayama et al., 1992) . In human breast carcinoma, reduced primary tumour nm23 expression has been shown to correlate with disease recurrence (Hirayama et al., 1991) , significant reductions in survival (Barnes et al., 1991; Hennessy et al., 1991) and the presence of lymph node metastases in one of three reported studies (Bevilacqua et al., 1989; Sastre-Garau et al., 1992; Dawkins et al., 1993) . This inverse correlation between low nm23-HJ/NDPK-A expression and some clinicopathological features has also been found in several other tumours studied, including human hepatocellular carcinoma (Nakayama et al., 1992) and melanoma (Florenes et al., 1992) . In other cancer types, however, nm23-HJ/NDPK-A may be irrelevant to metastatic tumour progression, or it may be altered by means other than reduced expression. In childhood neuroblastoma, for example, nm23 mutations have been found, and aggressive N-mycamplified stage III and IV tumours have been reported to express relatively high levels of Nm23-HI/NDPK-A (Leone et al., 1993b; Chang et al., 1994; Hailat et al., 1991) . Similarly, higher Nm23-Hl/NDPK-A expression levels have been correlated with high grade of malignancy in other neoplastic diseases, such as small-cell lung carcinomas (Engel et al., 1993) and prostate cancers (Igawa et al., 1994) .
Malignant lymphomas, Hodgkin's disease (HD) and nonHodgkin's lymphomas (NHL) constitute a heterogeneous group of disorders. NHL comprise tumours of different histogenesis and variable clinical outcomes. The indices most commonly used in the study of NHL, i.e. histological classification and staging, give an estimate of the average prognosis but do not accurately predict clinical outcome in individual cases. This is reflected within each of the major subgroups of this disease, i.e. low-grade and high-grade lymphomas, in which a great variation in the clinical pattern exists (Horning and Rosenberg, 1984; Gaynor and Ultmann, 1984) . Consequently, there is a need for reproducible quantitative methods of tumour description to confer additional prognostic information and so guide the clinician in the selection of the most appropriate therapeutic approach.
The aim of this study was to determine in a large series of primary childhood and adult lymphomas the pattern of nm23-HJ expression as the basis for future evaluation as a probable prognostic indicator, and whether the nm23-HJ gene is mutated in some of these tumour subtypes. As it has been shown that low proliferative activity was associated with low-grade NHL while high proliferative activity was associated with high-grade NHL (Kath et al., 1995) Figure 2 and summarised in Table I . The proliferative activity was evaluated using the Ki-67 specific monoclonal antibody MIB-1 (Dianova Hamburg, dia 505, dilution 1:10).
Statistical analyses were carried out using the nonparametric Kruskal-Wallis analysis of variance. A P-value less than 0.05 was considered to be statistically significant.
Northern blot analysis
Total RNA was extracted from primary snap-frozen lymphoma samples using the guanidinium isothiocyanate/ phenol method according to Chomcynzki et al. (1987) . Five micrograms of total RNA was resolved by electrophoresis on 1.2% agarose -formaldehyde gel and transferred onto Hybond N membrane (Amersham, Aylesbury, UK) according to standard protocols. Prehybridisation and hybridisation reactions were performed at 42°C in 50% (v/v) formamide, 5 x standard saline citrate (SSC), 50 mM Tris-HCl, pH 7.5, 5 x Denhardt's solution, 5% (w/v) sodium dodecyl sulphate (SDS), and 250 jMg ml-' denatured salmon sperm DNA and washed at a final stringency of 0.1 x SSC and 0.1% (w/v) SDS at 65°C. The blot was hybridised with a 32P-labelled cDNA fragment corresponding to a portion of the 3'-untranslated region specific for nm23-HJ (Stahl et al., 1991) , and hybridisation was detected by autoradiography. For multiple hybridisations, the bound probe was removed nm23-Hl mRNA and protein expression in lymphomas DNT Aryee et al by incubating the filter twice for O min in 0.1 x SSC and 0.1% SDS at 95 -100C. Quality and the comparable loading of RNA samples were confirmed by including ethidium bromide in the gels and by rehybridisation to ,B-actin cDNA respectively. PCR/SSCP analysis and DNA sequencing Three sets of primers were used separately for polymerase chain reaction (PCR) amplification of overlapping fragments from first-strand complementary DNA covering the entire coding sequence of nm23-HL. They were;
(1) nmSl: 5'-TGCTGCGAACCACGTGGGTC-3' and nmAl: 5'-GGACGGTCCTTCAGGTCAAC-3' (2) nmS2: 5'-GCTTCCGAAGATCTTCTCAAGA-3' and nmA2: 5'-CCAGTTCCTCAGGGTGAAACC-3' (3) nmS3: 5'-GCAGAGAAGGAGATCGGCTTG-3' and nmA3: 5'-CAGATGGTCGGGGATGGTAAC-3'.
Primers were selected on the basis of limiting the fragment sizes to less than 300 bp for SSCP analysis. Polymerase chain reactions were done using 1 pl of the first-round cDNAs with the appropriate primers in the presence of [32P]dCTP (3000 Ci mmol-') (Dupont NEN, Boston, MA, USA) in a 50 pl reaction volume as recommended by the manufacturer (Perkin Elmer Cetus, Norwalk, CT, USA). The following amplification conditions were used: 30 cycles of 94°C for 30 s, 62°C for 30 s and 72°C for 1 min, preceded by a 94°C, 10 min primary denaturation step and followed by a 72°C, 7 min final extension step. An aliquot of 1 p1 of each product was subsequently diluted 1: 20 with the loading buffer (95% formamide, 2 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol) and denatured at 90°C for 5 min. A 2 p1 aliquot was loaded onto a 6% acrylamide non-denaturing sequencing gel in 89 mM Tris-borate, 2 mM EDTA pH 8.3 and electrophoresed for 5 h at 4°C at 35 W. Gels were subsequently dried and bands visualised by autoradiography. DNA sequencing was performed on PCR-amplified nm23-HJ cDNA with the same primers as described above using the DNA cycle sequencing system (BRL, Gaithersburg, MD, USA), according to the manufacturer's instructions. Results nm23-H1 mRNA expression and mutational analysis Nm23-HJ RNA steady-state levels in 48 samples were determined in comparison with f,-actin and 18S rRNA by Northern blot analysis (Figure 1 ). Autoradiographs were semiquantitatively evaluated by densitometry. Representative data shown in Figure I indicate that, although both interand intra-subtype variations in band intensity for the nm23-HI 0.8 kb mRNA levels were observed, there was a trend towards higher expression levels in the high-grade NHL relative to the low-grade NHL. The nm23-HJ mRNA levels in some of the high-grade NHL were similar to that of the highly NDPK-A-expressing MCF-7 breast adenocarcinoma cells (Figure 1 ). The variation of nm23-HJ gene expression in the various lymphoma subtypes may have resulted from mutations in the coding region of the gene. To examine such a possibility, we screened for nm23-HJ gene mutations in 48 specimens by RT-PCR/SSCP analysis. None of the tumours showed aberrantly migrating bands in SSCP analysis with any of the primer sets used, which spanned the whole coding region. Twenty-four cDNA samples generated by PCR, representing the various lymphoma subtypes studied, were randomly chosen and the coding regions sequenced. None of these specimens harboured a mutation (data not shown).
Immunohistochemical reactivity of NDPK-A Paraffin-embedded, formalin-fixed sections from 106 resected primary lymphomas, well preserved for immunohistochemical analysis, were studied for tumour cell reactivity with the NDPK-A specific antibody 37.6. Both inter-and intra-subtype variations in NDPK-A expression were exhibited in the immunohistochemical stainings (Figure 2 ), which corroborated the RNA data. Results of the immunohistochemical analyses are summarised in Table I (Figure 2d and Table I ). In T-cell lymphomas, two tumour sites were investigated: nodal lymphomas and the clinically rather non-aggressive cutaneous lymphomas. In cutaneous T-cell lymphomas (CTCL) fewer immunoreactive cells were observed than in lymph node lymphomas with a similar morphology (e.g. pleomorphic CTCL contained usually lower fractions of reactive cells than the same type of nodal lymphomas). In contrast to high-grade B-cell lymphomas, we did not find striking discrepancies in staining intensity and positivity of cells when looking at T-cell precursor lymphoblastic lymphomas (Table I) . Anaplastic large-cell lymphomas (ALCL) behaved like other high-grade lymphomas, usually presenting with high rates of intensely stained tumour cells (Figure 2e) . In lymphadenitis, which was used as control, MAb 37.6 reactivity was observed mainly within the cytoplasm of blasts in reactive enlarged germinal centres. (Figure 2a ). Centrocytes and mantle cells were usually not stained. Centroblasts and, occasionally, starry-sky macrophages showed the highest reactivity. Within the T zones, single blastic T cells, plasma cells and histiocytes were weakly positive. Small lymphocytes were Mab 37.6 negative.
In Hodgkin's lymphoma, nodular sclerosing (NS) and mixed cellularity (MC) subtypes showed marked positivity of the Hodgkin and Reed-Sternberg cells. These neoplastic cells had the most intense cytoplasmic staining (Figure 2f ) when compared with the staining intensities of the different cellular components in high-grade NHL. Cells from the surrounding infiltrates such as lymphocytes or plasma cells showed weak staining ( Figure 2F ). In the lymphocyte-rich and, strikingly, lymphocyte-depleted subtypes, NDPK-A staining intensity of the neoplastic cells was lower than in both other subtypes ofHD.
Children usually present with high-grade lymphomas of the B and T type or Hodgkin's disease. They commonly do not present with low-grade lymphomas. Comparing the results between children (< 20 years) and adult cases of each subtype, no differences were observed in either staining patterns or intensity (Table I) .
Comparison of the proliferative activity and NDPK-A immunostaining in lymphomas MIB-1 is a monoclonal antibody that recognises the cell proliferation marker Ki-67 in paraffin-embedded tissues. To determine whether NDPK-A expression correlates with the proliferative activity, we stained all lymphoma specimens with the MIB-1 monoclonal antibody. Figure 2 shows representative Ki-67 antigen immunoreactivities. There was no conistent correlation between NDPK-A activity and proliferative activity (Table I) .
Correlation between histological subtype and NDPK-A expression As exemplified in Figure 2 and summarised in Table I (Bevilacqua et al., 1989; Barnes et al., 1991; Hennessy et al., 1991; Hirayama et al., 1991) , in which high nm23-H1/NDPK-A expression correlates with nonaggressive disease, our results show that, in lymphomas, highlevel nm23-HI/NDPK-A expression is found in high-grade subtypes, similar to the situation in Ewing tumours (Aryee et al., 1995) , neuroblastomas (Hailat et al., 1991) , lung carcinomas (Engel et al., 1993) and prostate cancers (Igawa et al., 1994) . These contrasting results might indicate that nm23-HI can function as a suppressor gene in some types of cancer and can be associated with tumour aggressiveness in others. This is in agreement with the situation in colorectal carcinomas, in which nm23-HJ mRNA expression is correlated with increasing colorectal cancer size and extent of local bowel invasion and therefore is speculated to be associated with local aggressive behaviour (Zeng et al., 1994) . Contrary to neuroblastomas, in which mutations in the nm23-HJ gene have also been associated with advanced stages of the disease (Chang et al., 1994) , no mutations have so far been found in any of the high-grade lymphomas analysed. Within the group of high-grade B-cell lymphomas, usually strong expression of NDPK-A was observed. In the heterogeneous group of precursor B lymphoblastic lymphomas, the mature types showed relatively higher expression levels than the immature types (pre-pre-B and pre-B) . These data might parallel the different clinical behaviour of these tumours as phenotypically mature lymphoblastic B-cell lymphomas require more aggressive and different chemotherapy regimens than the immature lymphomas.
The highest cytoplasmic staining intensity, even compared with the reactivity in high-grade NHL, was observed in HD. NDPK-A antigen was present on Hodgkin and ReedSternberg cells, whereas the accompanying plasma cells and lymphocytes showed only faint (if any) staining. In the classical forms of HD (NS, MC and LD), Hodgkin's and ReedSternberg cells express activation markers such as CD30, whereas they usually do not express T-or B-cell markers. The high expression levels of NDPK-A by Hodgkin and ReedSternberg cells might be interpreted in different ways because of the still enigmatic origin of the Hodgkin and Reed-Sternberg cell. NDPK-A expression paralleled proliferative activity in nodular scleroses and in the mixed cellularity form of HD but not in the lymphocyte-depleted subtype, which is known to have the worst prognosis of all HD subtypes.
The skin is a very common site for extranodal lymphoma origin. Usually, CTCL has a more favourable clinical course and is less aggressive than the T-cell lymphomas arising in lymph nodes. The nodal T-cell lymphomas analysed exhibited slightly higher NDPK-A expression levels compared with primary skin lymphomas of the same tumour morphology. This might reflect a correlation of NDPK-A expression to the clinical course of the disease subtypes. However, as the result of small patient numbers within the individual lymphoma subtypes, statistical evaluation of these small NDPK-A expression differences would be inappropriate and was not done. Although high-grade lymphomas usually have a high proliferative fraction and tend to exhibit more positivity for NDPK-A than low-grade lymphomas, we could not demonstrate a consistent correlation of NDPK-A expression with proliferation, as has been demonstrated for normal lymphoid cells (Keim et al., 1992) . There was also considerable intra-and inter-subtype variation of Ki-67 antigen immunoreactivity. Along a gradient among lowgrade lymphomas, NDPK-A expression appeared to parallel aggressive clinical course much more than Ki-67 staining (proliferation index), with mantle cell lymphoma exhibiting the highest NDPK-A expression. In addition to a general trend towards nm23-HJ expression paralleling aggressiveness of the different lymphoma subtypes, intra-subtype variations in nm23-HJ/NDPK-A were frequently observed in our study. We found neither correlation of NDPK-A expression with patient's age nor sex. As the tumour samples used for this study have been obtained from different centres, and most of the patients involved have been lost for follow-up, no statistical analysis of individual clinical courses in relation to NDPK-A expression was performed. Consequently, though our study underlines the biological importance of nm23-HJ expression for lymphomas, long term prospective studies with large numbers of patients for each histological subtype are warranted to statistically evaluate the prognostic significance for individual patients.
